Brookline, MA, United States of America

Maya Arai

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Maya Arai

Introduction

Maya Arai is a notable inventor based in Brookline, MA (US). She has made significant contributions to the field of biomedical research, particularly in the development of treatments for immune-related disorders. With a total of 2 patents, her work has the potential to impact the lives of many individuals suffering from various health conditions.

Latest Patents

Maya Arai's latest patents include groundbreaking methods of treatment utilizing binding proteins of the interleukin-21 receptor. This invention provides binding proteins and antigen-binding fragments that specifically target the human interleukin-21 receptor (IL-21R). These binding proteins can function as antagonists of IL-21R activity, thereby modulating immune responses. The disclosed methods may be utilized in diagnosing, treating, and preventing IL-21R-associated disorders, including inflammatory disorders, autoimmune diseases, allergies, and transplant rejection.

Another significant patent focuses on protein kinase C zeta as a drug target for arthritis and other inflammatory diseases. This invention is based on the discovery that the expression of PKC is increased in the tissues of arthritis patients compared to normal individuals. The patent provides methods for diagnosing and monitoring arthritis based on increased PKC gene expression. Additionally, it offers compounds that inhibit PKC expression for use as remedies in treating arthritis, including various pharmaceutical formulations and methods for assessing their efficacy.

Career Highlights

Maya Arai is currently associated with Wyeth, a prominent company in the pharmaceutical industry. Her work at Wyeth has allowed her to contribute to innovative research and development in the field of immunology and inflammatory diseases.

Collaborations

Maya has collaborated with esteemed colleagues, including Edward R LaVallie and Lisa Anne Collins-Racie. These collaborations have further enhanced her research and development efforts, leading to impactful innovations in her field.

Conclusion

Maya Arai's contributions to biomedical research through her patents and work at Wyeth highlight her dedication to advancing medical science. Her innovative approaches to treating immune-related disorders demonstrate the potential for significant improvements in patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…